St. Bernards Healthcare introduces Arkansas’s first FDA-approved, anesthesia-free tibial nerve implant for overactive bladder, offering same-day therapy with long-lasting, minimally invasive relief.

Adding one year of IMFINZI treatment to Bacillus Calmette-Guérin (BCG) induction and maintenance therapy delivered an early and sustained disease-free survival benefit vs. BCG alone WILMINGTON, Del.-- ...

Risk stratification frameworks guide NMIBC management, with intermediate-risk patients requiring nuanced decision-making due to high recurrence rates. The BCG shortage has increased reliance on ...

The PIVOT-006 trial is part of a larger national effort to evaluate cretostimogene’s safety and effectiveness in bladder cancer. Bladder cancer is one of the most common urological cancers, with ...

Intravesical therapy plays a crucial role in reducing the risk of recurrence and progression in patients with non-muscle invasive bladder cancer (NMIBC). Among the most widely used intravesical ...

A treatment’s safety and efficacy remain the gold standard in therapeutic innovation, but the most transformative medicines also succeed on another critical front: how seamlessly they integrate into a ...

The FDA has approved a gemcitabine intravesical system for Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), either with or without ...

Deion Sanders' cancer and new bladder procedure, explained originally appeared on Athlon Sports. Deion Sanders' offseason has been a doozy. The Hall-of-Famer and Colorado Buffaloes football coach ...

Deion Sanders’ offseason has been a doozy. The Hall-of-Famer and Colorado Buffaloes football coach recently revealed he underwent surgery to treat an aggressive form of bladder cancer. During an ...

PRINCETON, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative treatments for urothelial and specialty ...